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Abstract
Objective—We examined the roles of oncology providers in advance care planning (ACP) 
delivery in the context of a multidisciplinary cancer program.
Methods—Semi-structured interviews were conducted with 200 women with recurrent and/or 
metastatic breast or gynecologic cancer. Participants were asked to name providers they deemed 
important in their cancer care and whether they had discussed and/or completed ACP 
documentation. Evidence of ACP documentation was obtained from chart reviews.
Results—Fifty percent of participants self-reported completing an advance directive (AD) and 
48.5% had named a healthcare power of attorney (HPA), 38.5% had completed both, and 39.0% 
had completed neither document. Among women who self-reported completion of the documents, 
only 24.0% and 14.4% of women respectively had documentation of an AD and HPA in their 
chart. Completion of an AD was associated with number (adjusted odds ratio [AOR] = 1.49) and 
percentage (AOR = 6.58) of providers with whom the participant had a conversation about end-of-
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life decisions. Participants who named a social worker or nurse practitioner were more likely to 
report having completed an AD. Participants who named at least one provider in common (e.g., 
named the same oncologist) were more likely to have comparable behaviors related to naming a 
HPA (AOR = 1.13, p = 0.011) and completion of an AD (AOR = 1.06, p = 0.114).
Conclusions—Despite the important role of physicians in facilitating ACP discussions, 
involvement of other staff was associated with a greater likelihood of completion of ACP 
documentation. Patients may benefit from opportunities to discuss ACP with multiple members of 
their cancer care team.
Introduction
The Patient Self-determination Act (PSDA) aimed to empower patient participation in 
accepting or refusing medical treatment [1]. Evaluation of the PSDA has highlighted the 
importance of advance care planning (ACP), which is a broad construct that emphasizes the 
steps required to facilitate patients in guiding their future health care so that it is consistent 
with their goals when they are no longer capable of making decisions for themselves [2–4]. 
ACP can take many forms, including discussions about goals for care at the end of life, 
designation of a healthcare power of attorney (HPA), and completion of an advance directive 
(AD) or living will[5]. While not all ACP discussions result in power of attorney 
designations or completion of ACP forms, the presence of such is a marker that these 
discussions have occurred at least between patients and their family and/or friends.
While there have been a number of challenges identified with the ACP process [6–8], ACP 
has been shown to improve compliance with the end-of-life (EOL) wishes of patients, 
enhance patient and family satisfaction with care, and reduce family stress, anxiety, and 
depression [9,10]. Therefore, it is important to incorporate routine discussions about ACP 
with cancer patients at various points along the disease trajectory. We focused on women 
with recurrent and/or metastatic breast or gynecologic cancer. There are minimal standards 
for when ACP should be discussed with patients living with an advanced disease, including 
cancer. These include (a) at diagnosis of advanced cancer, (b) before an expected death from 
cancer, and (c) other sentinel events such as any hospital admission, admission to an 
intensive care unit, and before mechanical ventilation [2].
Most patients believe that addressing EOL issues is an important part of their cancer care 
[11,12]. Nevertheless, oncology providers often find it difficult to discuss ACP and EOL 
issues with patients and assume that patients will be hesitant or even unwilling to have the 
necessary conversations[13]. In fact, patients report being reluctant and feeling 
uncomfortable raising the issues themselves [3,14,15] but do want their physicians to initiate 
the discussions if and when they feel it is necessary [2,3,16].
Advance care planning has been poorly incorporated into many cancer care settings [17,18]. 
Understanding the structure and influence of patients’ social networks may be an important 
step to address the challenges associated with the ACP process and to develop novel 
approaches for ACP policies and programs. Social networks have been increasingly used to 
represent complex structures and relational patterns in a wide variety of disciplines [19,20]. 
However, there has been limited research applying networks to the understanding of 
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individual level healthcare decisions. There are a number of ways to conceptualize the role 
social networks may play in decision-making. The effect of the structure and activation of 
women’s personal networks can be considered such as network size, composition, and 
frequency of interaction. Alternatively, social networks can be defined more globally, 
capturing the extent to which women are aware of, and influenced by, the healthcare 
decisions being made by others such as through shared affiliations with health care 
providers.
Using a global conceptualization of social networks, we examined whether (a) women who 
reported having conversations about EOL wishes with their cancer care providers had a 
higher likelihood of the ACP behaviors of designation of a HPA and completion of an AD 
than women who did not report such conversations; (b) women who named particular types 
of providers (e.g., oncologist, surgeon, and non-physician provider) as important in their 
cancer care were more likely to report designating a HPA and completing an AD; and (c) 
women who had providers in common (e.g., named the same oncologist) were more likely to 
have similar ACP behaviors (e.g., named a HPA versus not).
While there are many potential measures of ACP, we focused on ADs or living wills and 
HPA because these were the focus of the law in place at the time in the state in which the 
research was conducted and because these two documents provide a procedural mechanism 
in which EOL plans can be legitimized, recorded, and shared [7]. Under the law, individuals 
have the right to instruct their physicians to withhold or withdraw life-sustaining procedures 
in the event of a terminal condition (establish a living will) [http://webserver.rilin.state.ri.us/
statutes/TITLE23/23-4.11/INDEX.HTM] and to authorize another person to make decisions 
affecting their healthcare if they become unable to do so (nominate a durable power of 
attorney for health care) [http://webserver.rilin.state.ri.us/statutes/TITLE23/23-4.10/
INDEX.HTM]. If individuals wish to name a durable power of attorney for health care, they 
must use the form in the statute. To establish a living will, they may use the statutory form or 
may create their own form if it meets the requirements of the law.
Relative to conventional cancer care settings, less is known about the experiences of patients 
and providers in settings using multidisciplinary integrated care models. This is particularly 
relevant because these programs are intended to be evidence-based, comprehensive, and 
patient-centered throughout the cancer care continuum [21,22] and may provide ideal 
settings for assessing social network approaches for ACP processes. Therefore, we examined 
experiences with ACP among patients in a multidisciplinary integrated program in women’s 
oncology.
Methods
Patients
Participants were recruited from the Program in Women’s Oncology at Women & Infants 
Hospital of Rhode Island, which employs a multidisciplinary care model. All patients are 
seen by a social worker at their initial visits, and care is rendered in a team approach, 
consisting of surgeons, medical oncologists, nurses, nurse practitioners, and specialty 
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pharmacists. The program also has integrative care available to all patients that includes 
dietitians, lymphedema and massage specialists, and mind–body practitioners.
Women were eligible if they had an established diagnosis of recurrent or metastatic breast or 
gynecologic cancer for at least 3 months duration. Only women were included because these 
were the patients cared for by the Program in Women’s Oncology. Women with recurrent or 
metastatic cancer were eligible because they were facing decisions about a potentially life-
threatening incurable condition and met the minimum standards for when ACP should be 
discussed.
Eligible patients were identified, recruited, and consented for participation by clinic 
personnel. After consent was obtained, in-person structured interviews were conducted by 
trained research staff. Clinical characteristics and evidence of ACP documentation were 
obtained from chart reviews. This study was approved by the hospital and University 
Institutional Review Boards.
Measures
Advance care planning—An AD or living will was defined for participants as ‘a set of 
written instructions in which you state the kind of health care you want or don’t want under 
certain circumstances’. We asked women if they had completed an AD, and if so, whether 
the timing of completion of the AD was related to the cancer diagnosis. If the timing was 
related to the cancer diagnosis, we asked whether it was related to the initial diagnosis or 
recurrence and whether they had changed the AD since being diagnosed with cancer. Among 
those for whom the timing was not associated with the cancer diagnosis, we asked for the 
circumstances prompting completion of the AD and whether the AD had been changed since 
the cancer diagnosis. A HPA was defined as ‘a document that must be signed by two 
witnesses or notarized in which you name someone to make decisions about your health care 
in the event you become incapacitated. The person is sometimes called a health care proxy 
or health care agent’. Similar to ADs, we asked about naming of, and timing and 
circumstances for, a HPA. Finally, chart reviews were completed by clinicians blinded to 
participants’ self-reported data to determine whether there was documentation of an AD 
and/or HPA in the medical record.
Provider characteristics—We asked women to name up to five healthcare providers that 
played important roles in their cancer care. This could include providers not affiliated with 
the oncology program such as primary care providers. Participants were then asked to 
describe each named provider’s specialty (e.g., oncologist and surgeon) and gender, and 
whether or not they had ever had a conversation with that provider about their wishes for 
care at the end of life.
Participant characteristics—Women were asked to self-report their age. From chart 
reviews, we determined cancer type, stage at initial diagnosis, and number of 
hospitalizations in the prior year.
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Statistical analyses
We first examined whether having a conversation about EOL wishes with a provider was 
associated with self-reported ACP. We created three variables quantifying the participants 
experiences with having conversations about EOL decisions with named providers: (a) the 
number of providers with whom the participant reported having an EOL conversation, (b) 
the percentage of providers with whom the participant reported having an EOL conversation, 
and (c) a dichotomous variable that indicated whether or not the participant reported having 
an EOL conversation with at least one named provider. We then tested the association 
between these three variables and completion of an AD and naming of a HPA.
Next, we examined whether participants who named a particular type of provider (e.g., 
oncologist, surgeon, and nurse practitioner) had significantly higher odds of ACP than those 
who did not name a particular type of provider. We created indicator variables for each 
provider type and computed a logistic regression model for each ACP outcome. The models 
included indicators for provider type, age, cancer type, stage, and hospitalization record.
Finally, we examined whether participants who shared common providers (e.g., named the 
same oncologist) were more likely to have the same ACP behaviors (e.g., completed an AD). 
First, two members of the research team formatted and then coded each of the provider 
names. Second, we determined all the unique pairs of participants (e.g., Participant 1 and 
Participant 2; Participant 1 and Participant 3). For each of these pairs, we determined 
whether they had named a common provider as well as had a similar age (within 5 years), 
stage at diagnosis, hospitalization record, and ACP behaviors. Next, using logistic regression 
modeling, we computed the odds of a pair of participants having the same ACP behaviors 
comparing those who shared a common provider to those who did not share a common 
provider, adjusting for age, stage, and hospitalization record. If the odds ratios were 
significantly different from 1.0, the probability of similar ACP behaviors was statistically 
associated with sharing a common provider. Because the pairwise observations were not 
independent, the standard errors and corresponding traditional statistical tests were not valid. 
Therefore, to account for the dependence within the observation of the pairs, we performed a 
Monte Carlo permutation to simulate the distribution of odds ratios under the null hypothesis 
that sharing a common provider was unrelated to similar ACP behaviors [23]. We repeated 
the analyses separately for completion of an AD and naming of a HPA.
For all analyses, we restricted the types of providers to oncologists, surgeons, nurse 
practitioners, oncology nurses, and social workers because these were the most common 
types of providers named by participants.
Because our primary modeling tool was logistic regression with the probability of the 
outcomes modeled as a function of individual and social network characteristics, the final 
sample size was based on our desire to ensure a reasonable denominator size across diverse 
modes of stratification. The sample size provided us the ability to detect odds ratios of 2.0 or 
greater as significant assuming two scenarios, stratification on a characteristic relevant for 
2/3 and 1/2 of the sample, respectively.
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Results
A total of 240 women were identified as eligible and recruited for participation. A total of 
210 (87.5%) women consented. Reasons given for refusal included the following: not being 
interested (n=15, 50.0%), being uncomfortable with the topic (n=5; 16.7%), feeling too ill to 
participate (n=4, 13.3%), and being too busy (n=1, 3.3%). Five women (16.7%) declined to 
provide a reason for non-participation. A total of 200 women(83.3% of those eligible and 
95.2% of those agreeing to participate) were interviewed. Of those not interviewed, eight 
refused after consent (five reported feeling too ill and three reported being too busy with 
health issues) and two died prior to the interview.
Demographic and clinical characteristics of the study sample are shown in Table 1. The 
mean age was 60 years (range = 35–82) years. The majority of participants had been 
diagnosed with ovarian, breast, or endometrial cancer with initial cancer stages of III or IV. 
One third of participants had been hospitalized at least once in the year prior to the interview 
and more than 80% had received two or more lines of treatment.
Half (50.0%) of participants self-reported completing an AD, and 48.5% had named a HPA, 
38.5% had completed both, and 39.0% had completed neither document. For the slightly 
more than half (55.0%) who reported completing the AD, the timing of the completion was 
not related to their original cancer diagnosis, but was performed as part of life/estate 
planning (54.0%) and/or prior to a surgery or a hospitalization (40.0%). Of women who 
completed an AD related to the cancer diagnosis (n=45), 73.3% did so at the time of the 
initial diagnosis. Among all participants with an AD, 12.7% had changed their AD since 
their index cancer diagnosis.
For 48.5% of those who named a HPA, the timing was not related to the cancer diagnosis. 
The primary reasons given by these women for naming a HPA were a surgery or 
hospitalization (59.8%) and/or part of life/estate planning (48.5%). Of women who named a 
HPA related to their cancer diagnosis (n=47), 78.7% did so at the time of the initial 
diagnosis. Among all participants who named a HPA, 6% had changed their HPA since their 
cancer diagnosis.
Despite these results, review of the medical charts showed that of women who self-reported 
completion of ACP documents, a documented AD and HPA was available for 24.0% and 
14.4% of all women, respectively.
There were 122 unique providers named by participants as important in their cancer care. 
The majority (75.5%) of participants did not report EOL conversations with any of the 
named providers. The adjusted odds ratios for completion of an AD and naming a HPA for 
each variable related to EOL conversations are presented in Table 2. Completion of an AD 
was positively associated with the number and percentage of providers with whom the 
participant had a conversation about EOL decisions, as well as having had an EOL 
conversation with at least one provider. However, none of these variables was associated 
with naming a HPA.
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The relationship between provider type and ACP behaviors are presented in Table 3. 
Participants who named social workers or nurse practitioners as important to their care were 
significantly more likely to report having completed an AD than participants who did not 
name those providers. There was no association between provider type and naming a HPA.
Participants who had at least one named provider in common had significantly higher odds 
of comparable behaviors related to naming a HPA (AOR = 1.13, p = 0.011) and higher, 
although not significant, odds of comparable behaviors related to completion of an AD 
(AOR = 1.06, p = 0.114).
Discussion
In a multidisciplinary program in women’s oncology, approximately 50% of women with 
recurrent or metastatic breast or gynecologic cancer reported having an AD and/or HPA. 
However, among women who self-reported completion of the documents, ADs and HPAs 
were recorded in the charts for only 24% and 14% of women, respectively. This is within the 
low-range to mid-range of what has been previously reported regarding patient-reported AD 
completion and clinician-documented ACP information described in other studies of patients 
with advanced cancer [13,24–26].
To our knowledge, this is the first study to use a social network approach to understand the 
roles of oncology providers in ACP processes. We found that having more than one provider 
involved in a patient’s care was positively associated with completion of an AD. In addition, 
women who shared at least one healthcare provider in common had a higher likelihood of 
similar ACP behaviors compared with women who did not share any providers in common. 
Not surprising, we also documented that women who reported EOL conversations with more 
providers had a higher likelihood of having an AD, after adjusting for possible confounders. 
These results suggest that patients of some providers are more likely to have considered 
ACP because these providers are more likely to engage their patients in EOL discussions. 
Alternatively, women with a tendency towards similar ACP decisions may be more likely to 
choose the same provider. Regardless, these data provide evidence that social network theory 
[19,20] may apply in this scenario and that patients may benefit from opportunities to 
discuss ACP with multiple members of their cancer care team.
Our data also suggest that the involvement of non-physician providers may have a positive 
relationship with ACP. Women who named a nurse practitioner or social worker as important 
in their cancer care were more likely to have an AD than women who did not name those 
kinds of providers after adjusting for age, stage of disease, severity of illness, and other 
types of providers named. Although we do not have data to explain these findings, social 
workers and nurse practitioners may have more training in, be more comfortable with, 
and/or have more time for ACP discussions than other types of providers. Women who were 
more inclined to complete an AD may also have sought out the care and advice of non-
physician providers perhaps because they had questions or concerns that were unaddressed 
by their physicians. These findings support the recommendations by You et al. [27] for the 
development of novel models to optimize inter-professional team members’ roles in 
facilitating communication and decision-making about goals of care.
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Our study has limitations that must be acknowledged. First, we had no way to confirm the 
validity of the self-reported or chart-documented ACP behaviors. While some women may 
have incorrectly self-reported their ACP behaviors, qualitative information suggests that it is 
more likely that ACP discussions, if conducted, were not consistently documented in the 
medical records. Furthermore, for 54% of women who completed an AD and 49% of those 
who named a HPA, ACP was performed as part of life/estate planning, and as a result, the 
documents may only be in attorney’s offices, particularly if women were not asked to 
provide copies by any medical personnel. Our data are also consistent with Morrison et al. 
who found that among the medical charts of patients who had completed a living will prior 
to being hospitalized, only 26% of the charts accurately recorded information about the AD 
and only 16% of the charts contained the form. [28] This highlights that programs and 
policies focused on enhancing and documenting the ACP process for cancer patients will 
likely be as beneficial to multidisciplinary cancer programs as to conventional programs [5] 
and may be facilitated with increased use of electronic health records and routine 
incorporation of ACP into clinical settings including regular inquiry as to whether such 
documents exist[7]. Second, we included women from only one multidisciplinary cancer 
program. Third, because women were not randomly assigned to providers, we cannot make 
any statements about causality. Fourth, participants were only asked to name up to five 
providers who were important in their cancer care. We may have observed stronger 
relationships if each participant was permitted to name more than five providers. Fifth, 
because all the non-physician providers included in the analyses were women, we were not 
able to test the relationship of provider gender on the ACP outcomes. Finally, we did not ask 
women in our study when they preferred to have conversations about EOL care. However, 
other studies indicate that cancer patients vary in their willingness to engage in, and 
preferred timing of, decisions about EOL issues [29–32]. Therefore, despite its importance, 
clinicians must acknowledge that some patients may reject the offer of this discussion at one 
or more stages of the cancer continuum[3]. Although we do not have data to provide 
confirmation, rejection of clinician offers to discuss EOL wishes may partially explain why 
a proportion of women in our study had not completed an AD or named a HPA.
Despite these limitations, our data support those of other studies that have called for 
programs to facilitate the training of, and implementation by, providers for EOL discussions 
with their patients [3,5] and completion of ACP documents. Inclusion of non-physician 
providers may be especially important. In addition, involvement of multiple provider types 
may facilitate ACP discussions given that the number of providers named was associated 
with increased rates of ACP completion, rather than the involvement of any one particular 
physician specialty. Alternatively, it may simply be important for at least one clinician to 
raise the topic of ACP at multiple points during a patient’s disease trajectory. Promising 
resources to aide in communication about ACP include programs such as the Physician 
Orders for Life-sustaining Treatment [33,34], Five wishes (www.agingingwithdignity.org), 
and Caring conversations [35]. In addition, web-based interventions [36,37], video 
educational media [38,39], and multi-media computer-based decisions aids [40] may offer 
opportunities to facilitate patients’ ACP. These types of resources along with clinical care 
protocols for consistent and routine conversations about ACP [7] can assure these planning 
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conversations are occurring and assist patients in identifying and articulating their goals and 
preferences in ways that help guide decision-making for surrogates and clinicians.
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What is already known about this topic?
Most patients believe that addressing EOL issues is an important part of their cancer care. 
However, oncology providers often find it difficult to discuss ACP and EOL issues with 
patients, and ACP has been poorly incorporated into many conventional cancer care 
settings.
What this paper adds?
Among women being cared for by a multidisciplinary program in women’s oncology 
who self-reported ACP, documentation of ADs and/or HPA was recorded in the medical 
charts for only 24% and 14.4% of women, respectively. Having more than one health care 
provider involved in a patient’s care had a positive association with self-reported 
completion of an AD. Women who named a nurse practitioner or social worker as 
important in their cancer care were more likely to self-report having an AD than women 
who did not name those kinds of providers. These findings support a potential role for 
members of a patient’s cancer care team beyond the oncologist in ACP. As such, there is 
need for programs to facilitate the training of, and implementation by, providers for EOL 
discussions with patients.
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Table 1
Demographic and clinical characteristics of study sample
Variable n %
Age (range: 35–82 years) Mean = 60.1 SD = 10.5
Hispanic ethnicity
 No 193 96.5
 Yes 6 3.0
 Don’t know/did not answer 1 0.5
Race
 White 181 90.5
 Not-White 19 9.5
Education
 High school or less 64 32.0
 Some college/technical training or certification 57 28.5
 College degree or higher 79 39.5
Employment
 Working full or part-time 44 22.0
 Unemployed 70 35.0
 Retired 85 42.5
 Don’t know/did not answer 1 0.5
Financial situation
 Not enough to pay some bills 26 13.0
 Enough to pay bills, but have had to cut back 42 21.0
 Enough to pay bills without cutting back but no extras 48 24.0
 Enough money for extras 81 40.5
 Don’t know/Did not answer 3 1.5
Cancer type
 Breast 56 28.0
 Cervical 12 6.0
 Endometrial 36 18.0
 Ovarian 82 41.0
 Endometrial and ovarian 1 0.5
 Other 13 6.5
Initial cancer stage
 I or II 69 34.5
 III or IV 127 63.5
 Missing 4 2.0
Number of hospitalizations in past year
 0 135 67.5
 1 41 20.5
 2 or more 24 12.0
Number of lines of treatment
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Variable n %
 1 29 14.5
 2 85 42.5
 3 86 43.0
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Table 2
Relationship between measures of end-of-life conversations with providers and advance care planning 
behaviors
Completion of an
advance directive
Naming of a
healthcare power
of attorney
AOR* 95% CI AOR* 95% CI
Model 1: Number of providers
with whom participant has had
a conversation about end-of-life
decisions
1.49 (1.06, 2.11) 1.01 (0.74, 1.39)
Model 2: Percentage of providers
with whom participant has had a
conversation about end-of-life
decisions
6.58 (1.70, 25.51) 1.78 (0.55, 2.12)
Model 3: Conversation about
end-of-life decisions with at least
one provider
Yes 3.26 (1.56, 6.83) 1.08 (0.55, 2.12)
No Reference
*
Models include participant age, cancer stage, cancer type, and hospitalization record
AOR, adjusted odds ratio; CI, confidence interval.
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Table 3
Relationship between provider type and advance care planning behaviors
Completion of an
advance directive
Naming of a healthcare
power of attorney
AOR 95% CI AOR 95% CI
Provider Type
Oncologist
 ≥1 named 2.15 (0.80, 5.77) 1.16 (0.45, 2.99)
 0 named Reference Reference
Surgeon
 ≥1 named 0.75 (0.37, 1.51) 0.53 (0.26, 1.05)
 0 named Reference Reference
Nurse practitioner
 ≥1 named 2.32 (1.01, 5.38) 1.08 (0.50, 2.34)
 0 named Reference Reference
Oncology nurse
 ≥1 named 0.90 (0.48, 1.70) 0.86 (0.46, 1.59)
 0 named Reference Reference
Social worker
 ≥1 named 2.72 (1.01, 7.40) 1.68 (0.65, 4.30)
 0 named Reference Reference
Participant characteristics
Age (in Years) 1.07 (1.04, 1.11) 1.04 (1.01, 1.08)
Cancer stage
 I/II 0.85 (0.44, 1.63) 1.17 (0.62, 2.20)
 III/IV Reference Reference
Cancer type
 Gynecologic 1.72 (0.82, 3.59) 0.71 (0.37, 1.38)
 Breast Reference Reference
Hospitalizations in past year
 0 0.94 (0.47, 1.85) 2.08 (1.02, 4.24)
 ≥1 Reference Reference
AOR, adjusted odds ratio; CI, confidence interval.
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